Company Overview - Lifeward is a global market leader in delivering life-changing solutions for rehabilitation, recovery, and empowering individuals with physical limitations or disabilities [7] - The company designs, develops, and commercializes innovative products such as the ReWalk Exoskeleton, AlterG Anti-Gravity System, MyoCycle FES System, and ReStore ExoSuit [11] - Founded in 2001, Lifeward has operations in the United States, Israel, and Germany [5] Shareholder Meeting Update - Lifeward has postponed its Extraordinary General Meeting of Shareholders from December 30, 2024, to January 13, 2025, due to an anticipated lack of quorum [7][8] - The record date for the meeting remains November 20, 2024, and shareholders who have already voted do not need to take further action unless they wish to change their vote [8] - The company plans to hold an Investor Day shortly after the postponed meeting, with the exact date to be confirmed [9] Proxy Statement and Shareholder Information - Lifeward filed a Definitive Proxy Statement with the SEC on November 25, 2024, which shareholders are urged to read carefully as it contains important information about the meeting [10] - Shareholders can access the proxy statement and other relevant documents on the SEC's website or the "SEC Filings" section of Lifeward's website [10]
Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders